We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cryo-Save | LSE:CRYO | London | Ordinary Share | NL0009272137 | ORD EUR0.10 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 420.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCRYO Cryo-Save Group NV 04 June 2010 ? 4 June 2010 Cryo-Save Group N.V. Scientists give the go-ahead for private storage of stem cells from umbilical cord blood Four world-renowned stem cell experts* have recently given their full support to private cordblood banking. The four scientists supported the foundation of the "Family Cord Blood Bank" which has just been established in the US by CORD:USE. Cryo-Save (Euronext/AIM: CRYO), the largest stem cell bank in Europe, is very pleased with this positive development. Arnoud van Tulder, Cryosave CEO said "We expect that the merit of private storage of stem cells will also increase in Europe and that the sometimes unreasonable arguments, which prevent people from storing stem cells in a number of countries, will disappear. Combined storage seems to be the way of the future". What is the merit of umbilical cord blood? Umbilical cord blood contains very valuable cells; stem cells which can multiply and grow into cells which can cure serious and sometimes deadly diseases. They are used to combat more than 70 different diseases and research into new applications is continuously increasing; at present, more than 3,000 clinical studies are in progress**. The blood and the stem cells are analyzed and processed using advanced technology and subsequently stored in the gas phase of liquid nitrogen. When needed, the cells can be used immediately. Private versus public storage? As a parent, you can have the umbilical cord blood with the stem cells of your child stored in the private or family blood bank. The stem cells are then available for later use and guarantee an exact match for the child concerned, and 25% chance that they are also an exact match for a brother or sister. Worldwide, hundreds of thousands of parents already decided to store the stem cells from the umbilical cord blood of their children in a private bank. When the choice is public storage, the parents decide to make the stem cells available to others. The cells can then be utilized to save the life of another, unknown person, who shows a match with the donor blood. However, the donor parents do not have any guarantee that the stem cells remain available for their own child as well. In addition, it turns out that only 30 to 50% of all donations are indeed stored. The rest is destroyed. You will only get the guarantee that the stem cells are available if your child needs them by storing in a private or family bank. Cryo-Save goes for combined storage With more than 130,000 samples stored and activities in more than 38 countries, Cryo-Save is the largest stem cell bank in Europe. The stem cells are taken from the umbilical cord and umbilical tissue. In Italy, Cryo-Save offers combined storage for both private as well as public use. This offers the guarantee that the blood is available for one's own child if it is ever needed, but is also available to help others. Pending approval of the authorities, Cryo-Save plans to introduce this "best-of-both worlds" combined-storage service in other countries as well. Cryo-Save (www.cryo-save.com) With more than 130,000 samples stored, Cryo-Save Group, with their head office in Zutphen, is the largest stem cell bank for stem cells from umbilical cord blood and umbilical cords in Europe and one of the fastest-growing in the world. Cryo-Save not only stores stem cells from the blood of the umbilical cord but distinguishes itself from its competitors in Europe, the United States and Asia by also storing a part of the umbilical cord itself which contains valuable mesenchymal stem cells (MSCs). Since May 21 of this year, Cryo-Save also stores MSCs from the fat tissue of adults (Cryo-Lip , http://www.cryo-lip.com). Driven by an international strategy, Cryo-Save is currently located in 38 countries on three continents. The enterprise has highly advanced technological laboratories and storage facilities in Belgium, Germany, Dubai, India and France (in construction). Note to editors ** www.clinicaltrials.gov/ct2/results?term=stem+cell * The scientific experts behind the public blood banks now also support the merit of private storage. Prof. Dr. Hal Broxmeyer, Prof. Dr. John Wagner, Prof. Dr. Joanna Kurtzberg and Prof. Dr. Elianne Gluckman are the main references worldwide as far as stem cell transplantations from umbilical cord blood are concerned. During the past 20 years, these stem cell experts have performed thousands of transplantations with stem cells from umbilical cord blood and have hundreds of publications to their credit. (More info at http://www.corduse.com). Prof. Hal Broxmeyer Professor Hal Broxmeyer is the founder of the public bank, CORD:USE Stem Cell Blood Bank, (Florida, USA)and president of the "American Society of Hematology" (16,000 members in 97 countries). He is internationally recognized as the founder of the field of stem cell transplantation using cells from umbilical cord blood. He was involved with the planning and coordination of the first successfully performed transplantation in 1988. Prof. John Wagner Professor John Wagner is the director of the "Stem Cell Institute of the University of Minnesota". He and his team were the first to use stem cells from the umbilical cord for the treatment of leukemia. Prof. Joanna Kurtzberg Professor Joanna Kurzberg is the director of "Duke University's Pediatric and Marrow Transplant Program" and performed the first ever successful transplantation with allogenous stem cells from umbilical cord blood in 1993. Prof. Elianne Gluckman Professor Elianne Gluckman is connected to the "Hematology University Paris VII" and president of the European School of Hematology. In 1988, she performed the first ever stem cell transplantation. http://www.corduse.com/public-cord-blood-bank/press_room/index.php?page=news&id 25&act=view For more information: Cryo-Save Group +31(0)575-548-998, Arnoud van Tulder, CEO, Marc Waeterschoot, Executive Director For more information about this press release, surf to http://www.cryo-savegroup.com/investor_news.html and http://www.cryo-savegroup.com/company_news.html This information is provided by RNS The company news service from the London Stock Exchange END NRABRGDLIGGBGGX
1 Year Cryo-Save Chart |
1 Month Cryo-Save Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions